1.110USD+1.83%Mkt Cap: 14.21M $P/E: —1d ago
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL l…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.96BUSD
$9.04BUSDP/E 23.0
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.80BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.40BUSDP/E 12.9
$2.31BUSD
$1.90BUSDP/E 19.2
$1.89BUSD
$1.86BUSDP/E 21.0
$1.89BUSD
$1.57BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.21BUSDP/E 38.0
$1.18BUSDP/E 17.6
$1.20BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$664.05MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$503.88MUSDP/E 14.2
$494.34MUSD
$463.93MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.08MUSDP/E 9.7
$285.23MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.51MUSDP/E 18.3
$146.07MUSD
$132.34MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$85.39MUSDP/E 12.3
$94.75MUSD
$72.08MUSD
$65.22MUSD
$70.06MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$63.41MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$48.31MUSD
$41.74MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.78MUSD
$17.65MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$2.08MUSDP/E 35.5
$1.85MUSD
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap14.21M $
Enterprise Value15.35M $
Revenue (TTM)43.20M $
Gross Profit30.74M $
Net Income (TTM)-10.54M $
Revenue/Share3.973 USD
Last Price1.110 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees84
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.47
PEG—
EV/EBITDA-1.45
EV/Revenue0.36
P/S0.33
P/B2.17
EPS (TTM)-0.98
EPS (Forward)0.32
52W Range
0.555085% of range1.205
52W High1.205 USD
52W Low0.5550 USD
Profitability
Gross Margin73.71%
Oper. Margin-38.95%
EBITDA Margin-24.45%
Profit Margin-25.26%
ROE-100.53%
ROA-36.89%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.36M $
CapEx (TTM)2.00K $
FCF Margin3.42%
FCF Yield10.39%
Net Debt1.40M $
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.59
Current Ratio1.21
Quick Ratio0.99
Book Value/Sh0.5110 USD
Cash/Share0.4940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 5, 2023
Analyst Consensus
Rating—
Target (Mean)5.875 USD
Upside (mean)+429.3%
Target Range2.750 USD – 9.000 USD
$2.750+429.3% to mean$9.000
# Analysts2
Ownership
Shares Out.12.80M
Float9.08M
Insiders13.18%
Institutions22.42%
Short Interest
Short Ratio0.1d
Short % Float0.23%
Short % Out.0.22%
Shares Short27.89K
Short (prev mo.)69.34K
Technical
SMA 500.9836 (+12.9%)
SMA 2000.9278 (+19.6%)
Beta0.82
S&P 52W Chg20.25%
Avg Vol (30d)309.04K
Avg Vol (10d)442.33K
Technical Indicators
RSI (14)57.6
MACD0.0410
MACD Signal0.0366
MACD Hist.+0.0044
BB Upper1.185 USD
BB Middle1.044 USD
BB Lower0.9021 USD
BB Width27.12%
ATR (14)0.0824 USD
Vol Ratio (20d)0.73x